
Acute zzso heart failure zzso is associated with increased hospitalization rates and high zzso zzso and has emerged as a major public health problem over the past zzso In recent years, several new drugs and therapeutic approaches have failed to reduce zzso and long-term morbidity and mortality in zzso zzso New agents and strategies are under investigation in order to effectively reduce the mortality and morbidity in these zzso 

To review the recent experimental and clinical evidence on existing therapeutic zzso and zzso drugs used for the treatment of zzso 

A systematic search of zzso publications was performed on zzso and zzso from January 1995 to January zzso The results of unpublished trials were obtained from presentations at national and international zzso 

Renal dysfunction and low zzso blood pressure zzso remain the main zzso of adverse clinical outcomes in zzso zzso Thus, therapy should be tailored according to the level of zzso at admission, zzso function and fluid zzso zzso due to zzso disease should be treated with intravenous zzso and zzso at low doses, while patients with low output syndrome need mainly zzso zzso However, few agents currently employed in the treatment of zzso have been shown in large prospective zzso clinical trials to improve clinical zzso The calcium zzso zzso is superior than traditional zzso in improving central zzso and zzso response in zzso patients, without increasing their long-term zzso zzso zzso also seem to be promising and safe drugs in the treatment of zzso patients, zzso zzso on top of zzso zzso zzso novel therapies include zzso zzso antagonists, zzso zzso cardiac zzso zzso and zzso 

Clinical scenarios based on zzso are essential zzso of therapeutic approaches used for the management of zzso Traditional drugs zzso zzso and zzso have several limitations in real clinical practice, and increase mortality zzso zzso drugs targeting to novel zzso concepts are promising treatment approaches and ongoing trials will define their clinical efficacy and zzso 

